Replies to post #161350 on Bioelectronics Corp (BIEL)

[misanthrope]

Why bother? FDA denied. BIEL has, as usual, no cash, so cannot pay the scaled down SEC fine. Future dilution 'imminent'. Expect BIEL to be someone's #1 stock pick for 2019 (and 2020, and 2021,......).

All that information that 'if we only knew' - now 'ya know, 2018 is a bust.

The product works by so many accounts that I have not doubt at all regarding its efficacy - sadly, successful products are, surprisingly often, not successful in the marketplace, nor do they always create successful companies.

Tsunami in progress - a sea of red and those trips we 'would never see again'.

So many are surely glad they ignored that 'why buy BIEL today and not tomorrow' nonsense........ouch

[Investor100]

Shareholder Conference Call Request

It is overdue that we have a shareholder conference call from CEO A. Whelan given this stock FDA status and would like to know what the plans are for the balance of 2018 and 2019.

I am holding a significant position, been using the product successfully for ten years but missing in all this is a shareholder meeting.

No luck need just some patience.

Investor 100